세계의 아스페르길루스증(Aspergillosis) 치료 시장 보고서(2025년)

Aspergillosis treatment refers to addressing a fungal infection caused by the aspergillus species, with the specific approach depending on the severity and type of the disease. Aspergillosis can pose a serious and potentially life-threatening threat, particularly to individuals with compromised immune systems.

The primary categories of aspergillosis treatment encompass allergic aspergillosis, chronic aspergillosis, invasive aspergillosis, and other variants. Allergic aspergillosis, also recognized as allergic bronchopulmonary aspergillosis (ABPA), denotes a specific allergic response to the Aspergillus fungus, most frequently associated with Aspergillus fumigatus. Various classes of drugs are utilized, including corticosteroids, antifungal medications, and others. These treatments can be administered through oral, injectable, and alternative routes, and are distributed through a range of channels such as hospital pharmacies, retail pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The aspergillosis treatment market research report is one of a series of new reports from The Business Research Company that provides aspergillosis treatment market statistics, including aspergillosis treatment industry global market size, regional shares, competitors with an aspergillosis treatment market share, detailed aspergillosis treatment market segments, market trends and opportunities and any further data you may need to thrive in the aspergillosis treatment industry. This aspergillosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The aspergillosis treatment market size has grown strongly in recent years. It will grow from $3.14 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to diagnostic advancements, demand for antifungal medications, increased incidence, invasive procedures.

The aspergillosis treatment market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to demand for transplant medicine, prevalence of hematologic malignancies, increasing investments in research and development, public health initiatives. Major trends in the forecast period include antifungal resistance, targeted therapies, therapeutic drug monitoring, drug development.

The forecast of 6.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. antifungal therapy by increasing the cost of voriconazole and amphotericin B formulations sourced from India and Spain, thereby delaying treatment for immunocompromised patients and elevating infectious disease department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of fungal infections is anticipated to drive the expansion of the aspergillosis treatment market. Fungal infections, or mycoses, are diseases caused by fungi that can affect both humans and animals. Aspergillosis, a specific type of fungal infection, can impact various parts of the body, including the respiratory system, lungs, brain, kidneys, and other organs. Treatments for aspergillosis, such as the antifungal medication voriconazole, aim to control infection, relieve symptoms, prevent complications, and enhance overall health. For example, in September 2023, the UK Health Security Agency reported an increase in bloodstream yeast infections in England, with cases rising from 3.8 per 100,000 people in 2021 to 4.0 in 2022. Consequently, the rising incidence of fungal infections is fueling growth in the aspergillosis treatment market.

Increasing healthcare expenditures are expected to drive growth in the aspergillosis treatment market. Healthcare expenditures encompass all costs related to health services, family planning, nutrition programs, and emergency health assistance. An increase in these expenditures supports the advancement of more effective treatments and medical technologies for managing aspergillosis. For example, in May 2023, the Office for National Statistics reported that healthcare spending in the UK reached approximately $362.08 billion (£292 billion), marking a 5.6% nominal increase. Additionally, spending on long-term health and social care rose by 2.8% in real terms in 2022. As a result, rising healthcare spending is bolstering the aspergillosis treatment market's growth.

Prominent companies in the aspergillosis treatment sector are dedicated to introducing cutting-edge drugs and solutions to maintain their competitive edge. These breakthroughs in drug development broaden the spectrum of treatment options available for aspergillosis. An example of this progress is the introduction of posaconazole oral suspension, which offers more precise and efficient treatment choices for patients. Notably, in April 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Posaconazole oral suspension in the US for treating aspergillosis. This medication is particularly relevant for patients with severely compromised immune systems, like hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD), who are at high risk of developing invasive aspergillus and candida infections. Furthermore, posaconazole oral suspension is recommended for oropharyngeal candidiasis (OPC), particularly when it proves refractory to itraconazole and fluconazole.

In May 2022, F2G Ltd., a pharmaceutical company based in England, entered into a partnership with Shionogi & Co., Ltd. to advance the development and commercialization of olorofim, an innovative antifungal treatment for invasive fungal infections, including invasive aspergillosis, across Europe and Asia. Shionogi & Co., Ltd., headquartered in Japan, specializes in developing treatments for invasive aspergillosis and other serious fungal infections.

Major companies operating in the aspergillosis treatment market are Basilea Pharmaceutica Ltd., Pfizer Inc., Johnson and Johnson, AbbVie Inc., Bayer AG, Novartis AG, Merck and Co. Inc., Sanofi S.A., Bristol Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, Astellas Pharma Inc., Regeneron Pharmaceuticals, Mylan N.V., Sun Pharmaceutical Industries, Jazz Pharmaceuticals, Dr. Reddy's Laboratories, Cipla Ltd., Bruker Corporation, Hikma Pharmaceuticals PLC.

North America was the largest region in the aspergillosis treatment market in 2024. The regions covered in aspergillosis treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aspergillosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aspergillosis treatment market consists of sales of immunotherapy drugs, echinocandin and azole antifungals. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aspergillosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aspergillosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aspergillosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aspergillosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Allergic Aspergillosis; Chronic Aspergillosis; Invasive Aspergillosis; Other Type
• 2) By Drug Class: Corticosteroids; Antifungal drugs; Other Drug Class
• 3) By Route of Administration: Oral; Injectable; Other Route Of Administration
• 4) By Distribution Channel: Hospital pharmacies; Retail pharmacies; Other Distribution Channel
• Subsegments:
• 1) By Allergic Aspergillosis: Allergic Fungal Sinusitis; Allergic Bronchopulmonary Aspergillosis (ABPA)
• 2) By Chronic Aspergillosis: Chronic Pulmonary Aspergillosis; Chronic Cavitary Aspergillosis
• 3) By Invasive Aspergillosis: Pulmonary Invasive Aspergillosis; Disseminated Invasive Aspergillosis
• 4) By Other Type: Aspergilloma; Other Rare Forms of Aspergillosis
• Companies Mentioned: Basilea Pharmaceutica Ltd.; Pfizer Inc.; Johnson and Johnson; AbbVie Inc.; Bayer AG; Novartis AG; Merck and Co. Inc.; Sanofi S.A.; Bristol Myers Squibb Company; AstraZeneca plc; GSK plc; Takeda Pharmaceutical Company; Eli Lilly and Company; Gilead Sciences Inc.; Boehringer Ingelheim International GmbH; Teva Pharmaceutical Industries; Astellas Pharma Inc.; Regeneron Pharmaceuticals; Mylan N.V. ; Sun Pharmaceutical Industries; Jazz Pharmaceuticals; Dr. Reddy's Laboratories; Cipla Ltd.; Bruker Corporation; Hikma Pharmaceuticals PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aspergillosis Treatment Market Characteristics

3. Aspergillosis Treatment Market Trends And Strategies

4. Aspergillosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aspergillosis Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aspergillosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aspergillosis Treatment Market Growth Rate Analysis
• 5.4. Global Aspergillosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aspergillosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aspergillosis Treatment Total Addressable Market (TAM)

6. Aspergillosis Treatment Market Segmentation

• 6.1. Global Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Aspergillosis
• Chronic Aspergillosis
• Invasive Aspergillosis
• Other Type
• 6.2. Global Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Antifungal drugs
• Other Drug Class
• 6.3. Global Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Injectable
• Other Route Of Administration
• 6.4. Global Aspergillosis Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail pharmacies
• Other Distribution Channel
• 6.5. Global Aspergillosis Treatment Market, Sub-Segmentation Of Allergic Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allergic Fungal Sinusitis
• Allergic Bronchopulmonary Aspergillosis (ABPA)
• 6.6. Global Aspergillosis Treatment Market, Sub-Segmentation Of Chronic Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Pulmonary Aspergillosis
• Chronic Cavitary Aspergillosis
• 6.7. Global Aspergillosis Treatment Market, Sub-Segmentation Of Invasive Aspergillosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pulmonary Invasive Aspergillosis
• Disseminated Invasive Aspergillosis
• 6.8. Global Aspergillosis Treatment Market, Sub-Segmentation Of Other Type, By type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Aspergilloma
• Other Rare Forms of Aspergillosis

7. Aspergillosis Treatment Market Regional And Country Analysis

• 7.1. Global Aspergillosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aspergillosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aspergillosis Treatment Market

• 8.1. Asia-Pacific Aspergillosis Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aspergillosis Treatment Market

• 9.1. China Aspergillosis Treatment Market Overview
• 9.2. China Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aspergillosis Treatment Market

• 10.1. India Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aspergillosis Treatment Market

• 11.1. Japan Aspergillosis Treatment Market Overview
• 11.2. Japan Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aspergillosis Treatment Market

• 12.1. Australia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aspergillosis Treatment Market

• 13.1. Indonesia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aspergillosis Treatment Market

• 14.1. South Korea Aspergillosis Treatment Market Overview
• 14.2. South Korea Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aspergillosis Treatment Market

• 15.1. Western Europe Aspergillosis Treatment Market Overview
• 15.2. Western Europe Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aspergillosis Treatment Market

• 16.1. UK Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aspergillosis Treatment Market

• 17.1. Germany Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aspergillosis Treatment Market

• 18.1. France Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aspergillosis Treatment Market

• 19.1. Italy Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aspergillosis Treatment Market

• 20.1. Spain Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aspergillosis Treatment Market

• 21.1. Eastern Europe Aspergillosis Treatment Market Overview
• 21.2. Eastern Europe Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aspergillosis Treatment Market

• 22.1. Russia Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aspergillosis Treatment Market

• 23.1. North America Aspergillosis Treatment Market Overview
• 23.2. North America Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aspergillosis Treatment Market

• 24.1. USA Aspergillosis Treatment Market Overview
• 24.2. USA Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aspergillosis Treatment Market

• 25.1. Canada Aspergillosis Treatment Market Overview
• 25.2. Canada Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aspergillosis Treatment Market

• 26.1. South America Aspergillosis Treatment Market Overview
• 26.2. South America Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aspergillosis Treatment Market

• 27.1. Brazil Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aspergillosis Treatment Market

• 28.1. Middle East Aspergillosis Treatment Market Overview
• 28.2. Middle East Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aspergillosis Treatment Market

• 29.1. Africa Aspergillosis Treatment Market Overview
• 29.2. Africa Aspergillosis Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aspergillosis Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aspergillosis Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aspergillosis Treatment Market Competitive Landscape And Company Profiles

• 30.1. Aspergillosis Treatment Market Competitive Landscape
• 30.2. Aspergillosis Treatment Market Company Profiles
  • 30.2.1. Basilea Pharmaceutica Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Johnson and Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Aspergillosis Treatment Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Merck and Co. Inc.
• 31.3. Sanofi S.A.
• 31.4. Bristol Myers Squibb Company
• 31.5. AstraZeneca plc
• 31.6. GSK plc
• 31.7. Takeda Pharmaceutical Company
• 31.8. Eli Lilly and Company
• 31.9. Gilead Sciences Inc.
• 31.10. Boehringer Ingelheim International GmbH
• 31.11. Teva Pharmaceutical Industries
• 31.12. Astellas Pharma Inc.
• 31.13. Regeneron Pharmaceuticals
• 31.14. Mylan N.V.
• 31.15. Sun Pharmaceutical Industries

32. Global Aspergillosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aspergillosis Treatment Market

34. Recent Developments In The Aspergillosis Treatment Market

35. Aspergillosis Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Aspergillosis Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aspergillosis Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aspergillosis Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer